title: Everolimus-Induced Symmetrical Drug-Related Intertriginous and Flexural Exanthema (SDRIFE).
authors.affiliation: Department of Dermatology, Brigham and Women's Hospital, Boston, MA dkurtzman@partners.org Division of Dermatology, University of Arizona College of Medicine, Tucson, AZ From the Department of Dermatology, Brigham and Women's Hospital, Boston, MA.
authors.forename: Drew Joseph Benedict
authors.initials: DJ
authors.lastname: Kurtzman
authors.forename: Jeremy
authors.initials: J
authors.lastname: Oulton
authors.forename: Christopher
authors.initials: C
authors.lastname: Erickson
authors.forename: Clara
authors.initials: C
authors.lastname: Curiel-Lewandrowski
mesh_terms: D000230:Adenocarcinoma / Q000188:drug therapy*; D000077192:Adenocarcinoma of Lung; D000368:Aged; D000970:Antineoplastic Agents / Q000009:adverse effects*; D003875:Drug Eruptions / Q000209:etiology*; D000068338:Everolimus / Q000009:adverse effects*; D006801:Humans; D008175:Lung Neoplasms / Q000188:drug therapy*; D008297:Male
chemical_list: D000970:Antineoplastic Agents; D000068338:Everolimus